(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 7.14% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.96%.
Sotera Health Co's revenue in 2026 is $1,150,379,000.On average, 11 Wall Street analysts forecast SHC's revenue for 2026 to be $352,276,471,960, with the lowest SHC revenue forecast at $337,503,587,652, and the highest SHC revenue forecast at $369,038,013,771. On average, 11 Wall Street analysts forecast SHC's revenue for 2027 to be $373,583,516,635, with the lowest SHC revenue forecast at $355,685,599,108, and the highest SHC revenue forecast at $393,470,091,665.
In 2028, SHC is forecast to generate $403,129,285,251 in revenue, with the lowest revenue forecast at $391,197,340,233 and the highest revenue forecast at $419,038,545,275.